Seneca Biopharma Up 151% on Meetings With Potential Partners, Drug Presentations
Seneca Biopharma Up 151% on Meetings With Potential Partners, Drug Presentations
DJ Seneca Biopharma Up 151% on Meetings With Potential Partners, Drug Presentations
By Josh Beckerman
Seneca Biopharma Inc. (SNCA) shares recently traded up 151% to $3.14 Friday after the company noted "meetings with potential joint venture and strategic partners" in a Thursday securities filing.
The company released slides presented at two conferences this week that detailed the potential uses for NSI-566 in amyotrophic lateral sclerosis, chronic ischemic stroke and chronic spinal cord injury.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
January 17, 2020 13:22 ET (18:22 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
DJ Seneca Biopharma Up 151% on Meetings With Potential Partners, Drug Presentations
DJ Seneca Biophma在與潛在合作伙伴的會議上上漲151%，藥物演示
By Josh Beckerman
喬什·貝克曼(Josh Beckerman)著
Seneca Biopharma Inc. (SNCA) shares recently traded up 151% to $3.14 Friday after the company noted "meetings with potential joint venture and strategic partners" in a Thursday securities filing.
Seneca Biophma Inc.(SNCA)股價上週五上漲151%，至3.14美元，此前該公司在週四的一份證券申報文件中指出，該公司“與潛在合資企業和戰略合作伙伴舉行了會議”。
The company released slides presented at two conferences this week that detailed the potential uses for NSI-566 in amyotrophic lateral sclerosis, chronic ischemic stroke and chronic spinal cord injury.
該公司本週在兩次會議上發佈了幻燈片，詳細介紹了NSI-566在肌萎縮側索硬化症、慢性缺血性中風和慢性脊髓損傷中的潛在用途。
Write to Josh Beckerman at josh.beckerman@wsj.com
寫信給喬什·貝克曼(Josh Beckerman)，電子郵件：josh.beckerman@wsj.com
(END) Dow Jones Newswires
(完)道瓊通訊社
January 17, 2020 13:22 ET (18:22 GMT)
2020年1月17日美國東部時間13：22(格林尼治標準時間18：22)
Copyright (c) 2020 Dow Jones & Company, Inc.
版權所有(C)2020道瓊斯公司。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧